SARS-CoV-2 recombinant XN, Italy

doi:10.1016/j.jcvp.2022.100084

. 2022 Aug;2(3):100084.

doi: 10.1016/j.jcvp.2022.100084. Epub 2022 May 21.

SARS-CoV-2 recombinant XN, Italy

Federica Novazzi¹, Daniele Focosi², Andreina Baj¹, Andrea Ambrosini³, Sara Bouthar¹, Fabrizio Maggi¹

Affiliations

¹ Department of Medicine and Surgery, University of Insubria, Varese, Italy.
² North-Western Tuscany Blood Bank, Pisa, Italy.
³ Nephrology Department, ASST-Settelaghi and University of Insubria, Varese, Italy.

PMID: 35620035
PMCID: PMC9122836
DOI: 10.1016/j.jcvp.2022.100084

SARS-CoV-2 recombinant XN, Italy

Federica Novazzi et al. J Clin Virol Plus. 2022 Aug.

. 2022 Aug;2(3):100084.

doi: 10.1016/j.jcvp.2022.100084. Epub 2022 May 21.

Authors

Federica Novazzi¹, Daniele Focosi², Andreina Baj¹, Andrea Ambrosini³, Sara Bouthar¹, Fabrizio Maggi¹

Affiliations

¹ Department of Medicine and Surgery, University of Insubria, Varese, Italy.
² North-Western Tuscany Blood Bank, Pisa, Italy.
³ Nephrology Department, ASST-Settelaghi and University of Insubria, Varese, Italy.

PMID: 35620035
PMCID: PMC9122836
DOI: 10.1016/j.jcvp.2022.100084

No abstract available

Keywords: Epidemiology; Italy; SARS-CoV-2; XN recombinant.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Cited by

Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.
Wang Y, Long Y, Wang F, Li C, Liu W. Wang Y, et al. Int J Med Sci. 2023 Jan 1;20(1):151-162. doi: 10.7150/ijms.79116. eCollection 2023. Int J Med Sci. 2023. PMID: 36619228 Free PMC article. Review.
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy.
Rueca M, Giombini E, Gramigna G, Gruber CEM, Fabeni L, Corpolongo A, Mazzotta V, Corso L, Butera O, Valli MB, Carletti F, Pignalosa S, Vairo F, Nicastri E, Antinori A, Girardi E, Vaia F, Maggi F, Sars CoV-Lazio Surveillance Study Group. Rueca M, et al. Diagnostics (Basel). 2022 Sep 14;12(9):2219. doi: 10.3390/diagnostics12092219. Diagnostics (Basel). 2022. PMID: 36140622 Free PMC article.
Characterization of SARS-CoV-2 genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population.
Oyola S. Oyola S. Res Sq [Preprint]. 2023 Oct 27:rs.3.rs-3457875. doi: 10.21203/rs.3.rs-3457875/v1. Res Sq. 2023. Update in: J Virol. 2025 Jun 17;99(6):e0048225. doi: 10.1128/jvi.00482-25. PMID: 37961584 Free PMC article. Updated. Preprint.

References

1. Focosi D., Maggi F. Recombination in Coronaviruses, with a focus on SARS-CoV-2. Rev. Med. Virol. 2022 in press. - PMC - PubMed
1. Hirotsu Y., Maejima M., Shibusawa M., et al. Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data. 2022:2022.2004.2003.22273268. - PMC - PubMed
1. Gu H., Ng D., Liu G., et al. Detection of a BA.1/BA.2 recombinant in travelers arriving in Hong Kong. Emerging Infect. Dis. 2022;28(6) 2022202220032028. - PMC - PubMed
1. Colson P., Delerce J., Marion-Paris E., et al. A 21L/BA.2-21K/BA.1 Mix Omicron SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis. medRxiv. 2022;2022 2003.2028. - PMC - PubMed
1. SARS-CoV-2 lineages. Accessed online at https://cov-lineages.org/lineage_list.html on April 25, 2022.

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] Focosi D., Maggi F. Recombination in Coronaviruses, with a focus on SARS-CoV-2. Rev. Med. Virol. 2022 in press. - PMC - PubMed

[2] Focosi D., Maggi F. Recombination in Coronaviruses, with a focus on SARS-CoV-2. Rev. Med. Virol. 2022 in press. - PMC - PubMed

[3] Hirotsu Y., Maejima M., Shibusawa M., et al. Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data. 2022:2022.2004.2003.22273268. - PMC - PubMed

[4] Hirotsu Y., Maejima M., Shibusawa M., et al. Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data. 2022:2022.2004.2003.22273268. - PMC - PubMed

[5] Gu H., Ng D., Liu G., et al. Detection of a BA.1/BA.2 recombinant in travelers arriving in Hong Kong. Emerging Infect. Dis. 2022;28(6) 2022202220032028. - PMC - PubMed

[6] Gu H., Ng D., Liu G., et al. Detection of a BA.1/BA.2 recombinant in travelers arriving in Hong Kong. Emerging Infect. Dis. 2022;28(6) 2022202220032028. - PMC - PubMed

[7] Colson P., Delerce J., Marion-Paris E., et al. A 21L/BA.2-21K/BA.1 Mix Omicron SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis. medRxiv. 2022;2022 2003.2028. - PMC - PubMed

[8] Colson P., Delerce J., Marion-Paris E., et al. A 21L/BA.2-21K/BA.1 Mix Omicron SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis. medRxiv. 2022;2022 2003.2028. - PMC - PubMed

[9] SARS-CoV-2 lineages. Accessed online at https://cov-lineages.org/lineage_list.html on April 25, 2022.

[10] SARS-CoV-2 lineages. Accessed online at https://cov-lineages.org/lineage_list.html on April 25, 2022.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SARS-CoV-2 recombinant XN, Italy

Affiliations

SARS-CoV-2 recombinant XN, Italy

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Miscellaneous